The unusual molecular makeup of Borrelia burgdorferi, which causes Lyme disease, may hold clues for understanding and treating the tick-borne disease.

Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results ...

This study presents a valuable meta-analysis that highlights low and highly variable breast cancer survival rates across Africa, emphasizing the pressing need for public health in Africa. The evidence ...

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines ...

Light helps us wake up, keeps us alert, and guides our sleep. But what happens when light becomes erratic? As a researcher ...

The results of an international study shed new light the underlying biological mechanisms which cause differences in health risks, symptoms and outcomes between males and females.

"Supply and demand" constraints limit the body's ability to produce the various proteins needed for critical life functions, ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), the Breast International Group (BIG), Institut Jules ...

Eukaryogenesis occurred suddenly, driven by the growing length of genes and the limitations on producing longer proteins. An ...

Initial proof-of-concept data from the ongoing BBI-355 Phase 1/2 POTENTIATE trial in patients with oncogene-amplified cancers anticipated in the second half of 2025 Novel Kinesin program on track for ...

This method provides rapid benefits, but has a higher potential to cause some anecdotal side effects, like digestive issues and bloating. Alternatively, you can take a single daily dose of 3 g for ...